Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, discussed the primary findings of their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health, focusing on patient and provider experiences.
Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey discussed the primary findings of their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health. In response to the COVID-19 pandemic, the program was created to promote home infusion of oncology therapeutics instead of receiving them at an oncology infusion center.
Jan went into more depth about the program and its findings during the AMCP Nexus session, "Implementation of a Novel Oncology Home Infusion Model" on October 18. At Horizon Blue Cross Blue Shield of New Jersey, she is the vice president and chief pharmacy officer. Jan is also professor emerita at Rutgers University's Ernest Mario School of Pharmacy.
Transcript
What were the primary findings of the pilot program, especially in terms of patient and provider experience?
It is one thing to say we are improving the delivery and making it accessible for the members to get it at home, but what is the member experience? What is the provider experience? We have gotten really good feedback from the members. The most positive experiences and testimonials have come from the members because they really liked the convenience of being at home. Even if they have side effects after the chemotherapy, they are at home, they are comfortable, they have a lot of access to the nurses, and, even through FaceTime, the providers—so they could talk—they could have that engagement with them, even after the infusion nurse had left the house.
Secondly, from a hospital perspective, this actually was very helpful from a provider perspective because what they did was that they backfilled those chairs with other infusions; they had limited capacity. So, now, when you move these infusions to home, those chairs then were utilized for other infusions that the hospital did not have enough chairs for, so that was a win for all of the stakeholders that were involved in this. The providers, initially, were a little skeptical, and we had the leadership really talk to them and say, "These are the drugs that the patient will be infused with at home, let us know if you have any concerns." Once they started doing it, their comfort level improved over time. Now, without thinking, they would refer the patients.
We also had a process developed as we started doing this intake and moving patients to home that we had to actually hide in the hospital setting a couple of technicians who could do the the process of identification and going through all the paperwork and everything else. That was something that was an operational enhancement in that original process, but that took away a lot of work burden from the hospital. Some of these infusions and chemotherapies could be 5 hours, 6 hours, 2 hours. If you take that time out of the resources at the hospital where we now have nursing shortages; during COVID-19, it was worse, but it still has not gone back to normal. Giving that [infusion] at a patient's home gave them [nurses] more resources to attend to other patients. Now, as the COVID-19 has subsided, going forward, it is something that is really being triggered by convenience, triggered by the fact that it is very convenient for the member to get it at home and not travel distances to get the infusion.
The other thing that was actually very important, which was not only because of COVID-19, but we learned that a lot of patients would miss chemotherapy. If you miss a cycle, then the next cycle is postponed. So, you are really impacting the outcome of those therapies, and that was unusual circumstances, which was really enlightening for us to understand that sometimes people miss. Now, people can't miss when somebody's going to their homes and delivering the care. That was, I think, big learning that it [home infusion] is not only conducive to improve member experience, but it also helps in the outcomes of the therapy in general.
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
2 Commerce Drive
Cranbury, NJ 08512